Business Wire

ADVA

6.10.2020 09:02:14 CEST | Business Wire | Press release

Share
ADVA announces general availability of market’s most versatile DCSG operating system

ADVA (FSE: ADV) today announced the general availability of its Ensemble Activator , the market’s first carrier-grade network operating system (NOS) designed for disaggregated cell site gateways (DCSGs). Already successful in trials with multiple global mobile network operators (MNOs) including Telefónica and Vodafone, Ensemble Activator disaggregates hardware from software, giving customers new levels of agility and freedom. Developed as part of the Telecom Infra Project (TIP), the feature-rich software enables MNOs to move away from closed proprietary systems and build open, vendor-neutral transport infrastructure with best-of-breed components. Now ready for commercial deployment in mobile networks, it offers MNOs a clear route to cost-effective mass rollout of 5G services.

“Today’s announcement marks the start of a new age of disaggregated mobile networks. By deploying our Ensemble Activator, MNOs will be able to leverage the full benefits of separated software and hardware and inject unprecedented speed, efficiency and flexibility into their transport infrastructure,” said Eli Angel, VP, product line management, Ethernet access, ADVA. “Built on our team’s vast experience equipping the largest public networks with the most advanced connectivity solutions, Ensemble Activator has now proven itself in a wide range of real-life scenarios. These include 5G field trials where Ensemble Activator combined with third-party white box hardware to create an open and cohesive DCSG solution . By turning cost-effective bare-metal switches into powerful packet network devices, it will equip MNOs to build tomorrow’s mobile infrastructure.”

Engineered through the TIP Disaggregated Cell Site Gateway group, ADVA’s Ensemble Activator is optimized for the operation of large, geographically dispersed networks. Proven in multiple tests with third-party hardware from suppliers such as Alpha Networks, Delta and Edgecore, it integrates seamlessly into existing management and control systems. With its carrier-class capabilities, Ensemble Activator offers a way to grow mobile networks that combines the agility of software-based feature development with the performance and cost-efficiency of bare-metal switches. Its comprehensive set of CE 2.0- and MEF 3.0-compliant interfaces is complemented with proven IP and MPLS protocols. What’s more, with its open control interfaces and telemetry streaming, Ensemble Activator is a significant step towards automated and eventually autonomous operations.

“Supporting the disaggregation of hardware and software while meeting the performance needs of the most demanding mobile networks is critical in transitioning today’s technology to open, highly scalable mobile transport architectures and enabling the mass rollout of 5G services. We are very excited about ADVA’s Ensemble Activator, as it offers something new to the market and enables a strong ecosystem for DCSG technology,” commented Luis MartinGarcia, manager, network technologies, Facebook and co-chair, DCSG group, TIP. “TIP is all about unleashing the power of collaboration and open innovation, and ADVA’s work demonstrates how quickly we build together in TIP to bring a powerful new technology to maturity.”

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel

China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release

The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,

Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release

Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,

KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release

Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye